UBS cuts Bristol-Myers Squibb stock target, keeps neutral stance on Q2 earnings - Investing.com
Bristol-Myers Squibb Co. · PHARMACEUTICAL PREPARATIONS · Now $54.95
+2.0% in 3d after detection
Post-detection moves
1h
—
1d
+0.4%
3d
+2.0%
7d
-1.9%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS